Evidence map›Paper›PMID 40477429›Full record

ReviewRevista colombiana de reumatologia2022

[Pulmonary manifestations of rheumatoid arthritis, a review in SARS-CoV-2 pandemia].

B Juan David Orozco, S Alex Jhonier Imbachí, Ana Isabel Ospina

Abstract readEnglish AbstractReview
In one paragraph

Review in Revista colombiana de reumatologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

B Juan David OrozcoDepartamento de Medicina Interna, Facultad de Medicina, Universidad del Cauca, Hospital Universitario San José, Popayán, Colombia.
S Alex Jhonier ImbachíDepartamento de Medicina Interna, Facultad de Medicina, Universidad del Cauca, Hospital Universitario San José, Popayán, Colombia.
Ana Isabel OspinaServicio de Reumatología, Departamento de Medicina Interna, Facultad de Medicina, Universidad del Cauca, Hospital Universitario San José, Popayán, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is one of the most frequent chronic autoimmune pathologies. It's prevalence varies from 0.5 to 1%, with a primary involvement at the joint, generating disability due to deformities secondary to persistent inflammation. Considering the high impact on the quality of life of those who suffer it, added to the high cost of therapeutic interventions, it becomes imperative for health personnel to join forces to promote early diagnosis and recognize potential complications, in order to impact positively on clinical outcomes. Around 50% of patients with RA may have extra-articular involvement, the lung being one of the most affected organs. In times of SARS-CoV-2 pandemic, it's necessary to remember the types of lung involvement in patients with RA and take into account the susceptibility of these patients to infectious conditions that can generate great morbidity and mortality.

Indexed as

Airway obstructionInterstitial lung diseaseLung cancerLung involvementPulmonary noduleRespiratory infectionsRheumatoid arthritisSARS-coV 2TuberculosisVascular disease

Identifiers

PMID40477429
PMCPMC7934669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.